The Report Guru

The Breast Imaging Market is projected to reach USD 6.6 billion by 2028, with a CAGR of 8.5% from 2023 to 2028. The report titled "Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecasts to 2028" highlights key factors driving market growth, such as rising awareness campaigns, increasing public-private investments, and lucrative opportunities in emerging markets. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897 Technology Segment Analysis During the forecast period of 2023-2028, the non-ionizing breast imaging technologies segment is expected to experience significant growth, surpassing the ionizing breast imaging technologies segment, which held the highest market share in 2022. Product Segment Analysis In terms of product, the software & services se...

The global MIS instruments market is projected to generate $31.7 billion in revenue in 2024. This market is expected to grow at a compound annual growth rate (CAGR) of 9.5%, reaching $49.9 billion by 2029. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Key Market Segments and Insights Dominance of Handheld Instruments In 2020, the handheld instruments segment held the largest share of the MIS instruments market by product segment. The growth of this segment can be attributed to the cost-effectiveness of articulating laparoscopic handheld surgical instruments. These tools are extensively used in cardiothoracic, arthroscopy, urology, cardiovascular, and neurological surgeries. Hospitals and Specialty Clinics Lead The market is segmented by end user into hospitals and specialty clinics, and ambulatory surgery centers. In 2020, hospitals and specialty clinics dominated the market due to their substantial investments in lab automation and i...

The global gene editing market size in terms of revenue, was estimated at .3 billion in 2023 and is projected to reach .6 billion by 2028, showcasing a remarkable compound annual growth rate (CAGR) of 15.0% from 2023 to 2028. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 OPPORTUNITY: Expanding pipeline for gene therapy The expanding pipeline for gene therapy in the gene editing industry presents significant opportunities for advancements in treating genetic disorders and other diseases. Gene therapy involves the delivery of therapeutic genes or gene editing tools into the patient’s cells to correct genetic mutations, restore normal gene function, or introduce therapeutic genes for targeted treatment. The growing number of gene therapy candidates in the development pipeline highlights the potential for transformative breakthroughs in personalized medicine and the treatment of previously incurable diseases. CHALLENGE: High equi...

The global market for Monoclonal Antibody Therapeutics (mABs) is experiencing robust growth, driven by technological advancements, increasing prevalence of chronic diseases, and substantial investment in healthcare research and development. As CXOs, VPs, and directors navigate this dynamic landscape, understanding key market dynamics and current trends is essential for seizing emerging opportunities and overcoming challenges. Current Market Dynamics The size of the global monoclonal antibody therapeutics market was valued at approximately $252.6 billion in 2024 and is projected to reach $497.5 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.5% during the forecast period. This growth underscores the market's significance and potential for stakeholders across therapeutic segments including oncology, inflammatory & autoimmune diseases, and hematology. Technological advancements in production methods, particularly in-vitro and in-vivo techniques...

According to research report the report Dental Equipment Market is projected to grow from USD 6.5 billion in 2022 to USD 8.7 billion by 2027, at a compound annual growth rate (CAGR) of 6.1%. This significant growth is driven by advancements in dental technology, increasing prevalence of oral disorders, and a rising demand for cosmetic dental procedures. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784 Key Market Segments Therapeutic Dental Equipment: The Fastest Growing Segment The therapeutic dental equipment segment is expected to experience the highest growth rate between 2022 and 2027. This growth is primarily driven by the introduction of advanced technologies, such as electrosurgical devices, which offer benefits like lower operating costs, minimal bleeding, and reduced post-operative pain for patients. This segment includes dental chairs, dental units, CAD/CAM systems, casting machines, and dental lasers, including Nd and carbon di...

The report Spinal Implants Market by Product (Devices: Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion; Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028 projects the market to reach USD 14.3 billion by 2028, up from USD 11.2 billion in 2023, with a CAGR of 5.0% during the forecast period. Market growth is driven by increasing demand for minimally invasive surgical procedures, rising prevalence of spinal disorders, an aging population, increased public-private investments in clinical research, and the presence of key market players in developing regions. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 Non-Fusion Devices Segment The non-fusion devices segment is expected to register significant growth from 2022 to 2028. The spinal implants market is segmented by product into thoracic fusion and lumbar fusion devices, cervica...

The global cancer biomarkers market is experiencing significant growth and is projected to reach USD 42.0 billion by 2029, up from USD 24.5 billion in 2024, with a compound annual growth rate (CAGR) of 11.3%. This surge in growth can be attributed to several key factors, including the rising prevalence of cancer worldwide, increasing use of cancer biomarkers in drug discovery and development, and ongoing research and development efforts in the field of cancer biomarkers. Emerging markets such as India and Japan also offer lucrative opportunities for market players operating in this space. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202 Market Segmentation and Trends Biomarker Type The cancer biomarkers market is divided into three main segments based on biomarker type: protein, genetic, and other cancer biomarkers. In 2020, the protein biomarkers segment accounted for the largest market share, primarily due to ongoing technological advance...